|
Market Closed -
Nasdaq
23:00:00 16/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 12.35 USD | -3.29% |
|
+3.00% | +50.98% |
Company Valuation: ORIC Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 578.9 | 264.8 | 501.9 | 569.5 | 796.6 | 1,280 | - | - |
| Change | - | -54.26% | 89.55% | 13.47% | 39.89% | 60.69% | - | - |
| Enterprise Value (EV) | 578.9 | 264.8 | 266.8 | 569.5 | 751 | 1,280 | 1,280 | 1,280 |
| Change | - | -54.26% | 0.78% | 113.42% | 31.87% | 70.46% | 0% | 0% |
| P/E | -7.1x | -2.62x | -4.69x | -4.41x | -5.56x | -8.14x | -7.3x | -6.41x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.3x | 0.4x | 0.66x | 0.3x | -2.51x | -0.6x | -0.5x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 464x |
| EV / Revenue | - | - | - | - | - | - | - | 464x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -7.93x | -7.73x | -8.95x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -7.15x | -6.12x | -5.38x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -9.52x | -7.71x | -6.38x |
| FCF Yield | -10.4% | -29.2% | -17.2% | -20% | -14% | -10.5% | -13% | -15.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.07 | -2.25 | -1.96 | -1.83 | -1.47 | -1.518 | -1.691 | -1.927 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 2.757 |
| EBITDA 1 | -77.97 | -90.8 | -109.7 | -141.8 | -141.8 | -161.4 | -165.6 | -143 |
| EBIT 1 | -78.87 | -91.77 | -110.8 | -142.9 | -143 | -179 | -209.1 | -237.8 |
| Net income 1 | -78.72 | -89.12 | -100.7 | -127.8 | -129.5 | -166 | -199.2 | -249.4 |
| Net Debt | - | - | -235 | - | -45.67 | - | - | - |
| Reference price 2 | 14.70 | 5.89 | 9.20 | 8.07 | 8.18 | 12.35 | 12.35 | 12.35 |
| Nbr of stocks (in thousands) | 39,382 | 44,953 | 54,552 | 70,567 | 97,389 | 103,653 | - | - |
| Announcement Date | 3/21/22 A | 3/16/23 A | 3/11/24 A | 2/18/25 A | 2/23/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.14x | - | - | -.--% | 1.28B | |
| 18.77x | 6.69x | 13.41x | 1.58% | 65B | |
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | |
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | |
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | |
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | |
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | |
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | |
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | |
| 30.74x | 5.69x | 19.09x | -.--% | 22.5B | |
| Average | 22.68x | 26.57x | 15.32x | 0.29% | 37.37B | |
| Weighted average by Cap. | 25.85x | 25.01x | 15.48x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORIC Stock
- Valuation ORIC Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
